Transition Metal Chemistry
Scheme 2 Stereochemical
pathway giving (S)-3aa
diphenylphosphine group. The sterically favored transition
state B, minimizing unfavorable steric interaction between
the tertiary butyl group attached to the oxazoline ring and
the sulfonyl of imine substrate, leads to the product 3aa with
the S confguration that we obtained.
General procedure for the synthesis of product 3
Ligand L1 (6.2 mg, 7.5 mol%) and Pd(TFA)2 (3.4 mg,
5 mol%) were dissolved in unpurifed TFE (1.5 mL) in a
Schlenk tube. After 0.5 h of stirring at room temperature,
N-sulfonyl imine 1 (0.2 mmol) and arylboronic acid 2
(0.3 mmol) were added into the tube. The wall of the tube
was rinsed with an additional of TFE (0.5 mL). The mixture
was stirred at 40 °C for 2 h and then was diluted with EtOAc
and washed with saturated NH4Cl (aq). The organic layers
were dried over MgSO4 and fltered, and the solvents were
evaporated in vacuum. The residue was purifed by fash
column chromatography, eluting with petroleum ether and
ethyl acetate to aford the corresponding product 3.
Conclusions
In summary, palladium complexes generated in situ from
trifuoroacetate and SMI-PHOX ligand exhibited excellent
catalytic performance in Pd-catalyzed asymmetric arylation
of cyclic N-sulfonyl imines. Further application of these
ligands in other asymmetric transformations is currently
under development in our laboratory.
Compliance with ethical standards
Experimental sections
Conflict of interest There are no conficts to declare.
General
All air- and moisture-sensitive manipulations were carried
out with standard Schlenk techniques under argon. Commer-
cially available reagents were used without further purifca-
tion. Melting points were recorded on a RY-1 microscopic
melting apparatus and uncorrected. 1H and 13C NMR spec-
tra were recorded on a Bruker Avance 500 spectrometer.
Chemical shifts were reported in parts per million (δ) rela-
tive to tetramethylsilane (TMS). HRMS were performed on
an Ultima Global spectrometer with an ESI source. High-
performance liquid chromatography (HPLC) was performed
on a Shimadzu LC-20 Liquid Chromatograph using chiracel
OD-H, AD-H, AS-H, IA and IC columns. Ligands L1–L4
References
1. Wagstaff AJ, Ormrod D, Spencer CM (2001) CNS Drugs
15:231–259
2. Pfum DA, Krishnamurthy D, Han Z, Wald SA, Senanayake DH
(2002) Tetrahedron Lett 43:923–926
3. Stocchi F, Fossati C, Torti M (2015) Expert Opin Pharmacother
16:2231–2241
4. Wang H, Xu MH (2013) Synthesis 45:2125–2133
5. Wang H, Jiang T, Xu MH (2013) J Am Chem Soc 135:971–974
6. Jiang T, Wang Z, Xu MH (2015) Org Lett 17:528–531
7. Xie L, Ma HL, Li JQ, Yu Y, Qin ZH, Fu B (2017) Org Chem Front
4:1858–1862
8. Quan M, Tang L, Shen JQ, Yang GQ, Zhang WB (2017) Chem
Commun 53:609–612
9. Sun WY, Gu HR, Lin XF (2018) J Org Chem 83:4034–4043
10. Yang GQ, Zhang WB (2013) Angew Chem 125:7688–7692
11. Quan M, Yang GQ, Xie F, Gridnev ID, Zhang WB (2015) Org
Chem Front 2:398–402
12. Álvarez-Casao Y, Monge D, Álvarez E, Fernández R, Lassaletta
JM (2015) Org Lett 17:5104–5107
13. Zhang ZF, Butt NA, Zhang WB (2016) Chem Rev
116:14769–14827
1 3